Physician profile
Cheryl M Everitt
NPI 1164579918
$4,430.47
in general payments reported to CMS, 2019-2025
18 companies · $641 in 2025
The $641 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,252 · 2020: $660 · 2021: $79.42 · 2022: $281 · 2023: $160 · 2024: $358 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,282.37 | 2019-2025 | Precision7 |
| Tarsus Pharmaceuticals, INC. | $518.86 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $517.44 | 2019-2025 | Acuvue |
| Coopervision INC. | $219.76 | 2020-2025 | Cvi Contact Lens, Myday Contact Lens, Misight Contact Lens |
| Shire North American Group INC | $130.39 | 2019 | |
| Abbvie INC. | $111.62 | 2022-2023 | |
| Glaukos Corporation | $105.47 | 2022-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $104.33 | 2019 | |
| Bausch & Lomb Americas INC. | $100.50 | 2024-2025 | Miebo, Xiidra, Infuse |
| Visioneering Technologies, INC. | $97.59 | 2024 | |
| Abb Con-Cise Optical Group LLC | $83.26 | 2019-2021 | |
| Harrow Eye, LLC | $38.88 | 2025 | |
| Aerie Pharmaceuticals, INC. | $21.99 | 2020 | |
| Sight Sciences, INC. | $21.14 | 2021 | |
| Optos, INC. | $20.20 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $20.03 | 2023 | Cequa |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Everitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.